Anne Berscheid

Anne Berscheid

Auto-generated profile, based on publicly available information

Anne Berscheid

German Center for Infection Research (DZIF), partner site Tübingen, Tübingen, Germany

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2016 in Nature
Verified
Journal Article
Closed access
PDF file
AZAlexander Zipperer
Alexander Zipperer
MKMartin C. Konnerth
Martin C. Konnerth
CLClaudia Laux
Claudia Laux
ABAnne Berscheid
Anne Berscheid
DJDaniela Janek
Daniela Janek
BKBernhard Krismer
Bernhard Krismer

21 March 2017 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
JRJudith Raschig
Judith Raschig
DMDaniela Mailänder-Sánchez
Daniela Mailänder-Sánchez
ABAnne Berscheid
Anne Berscheid
JBJürgen Berger
Jürgen Berger
ASAdam A. Strömstedt
Adam A. Strömstedt
JWJan Wehkamp
Jan Wehkamp
Ever since the discovery of endogenous host defense antimicrobial peptides it has been discussed how these evolutionary conserved molecules avoid to induce resistance and to remain effective. Human ß-defensin 1 (hBD1) is an ubiquitously expressed endogenous antimicrobial peptide that exhibits qualitatively distinct activities between its oxidized and reduced forms. Here, we explore these antimicrobial mechanisms. Surprisingly, using electron microscopy we detected a so far unknown net-like structure surrounding bacteria, which were treated with the reduced but not the oxidized form of hBD1. A transmigration assay demonstrated that hBD1-derived nets capture bacteria and inhibit bacterial transmigration independent of bacterial killing. The presence of nets could completely prevent migration of hBD1 resistant pathogens and are stable in the presence of human duodenal secretion with a high amount of proteases. In contrast to HD6, cysteins are necessary for net formation. This redox-dependent function serves as an additional mechanism of action for hBD1 and differs from net formation by other defensins such as Paneth cell-derived human α-defensin 6 (HD6). While hBD1red and hBD1ox have distinct antimicrobial profiles and functions, only the reduced form provides additional host protection by entrapping bacteria in extracellular net structures preventing bacterial invasion. Better understanding of the modes of action of endogenous host peptides will help to find new antimicrobial strategies. The human body is constantly challenged by commensal and by pathogenic bacteria. Antimicrobial molecules of the innate immune system protect the human body from bacterial overgrowth and keep human microbiota in balance. One of the most prominent antimicrobial molecules is the human beta defensin 1 (hBD1). It is, in contrast to other defensins, constantly expressed by epithelial cells and exhibit diverse host antimicrobial strategies, which are much more complex than expected some years ago. Here, we aimed to study the unknown mechanisms of the different redox forms of hBD1. We detected, besides bacterial cell wall disruption, a so far unknown net-like structure surrounding bacteria, which entraps bacteria, independent of bacterial components and antimicrobial activity. Of note, these nets are depending on the amino acid cysteine and these nets are stable even in the presence of physiological human duodenal fluid. We demonstrated that net formation by reduced hBD1 prevents bacterial translocation, including hBD1 resistant pathogens. These findings highlight the complexity of these conserved antimicrobial defense mechanisms and help to find new antimicrobial strategies.

6 May 2019 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
PDF file
NSNadine Anna Schilling
Nadine Anna Schilling
ABAnne Berscheid
Anne Berscheid
JSJohannes Schumacher
Johannes Schumacher
JSJulian Sigfried Saur
Julian Sigfried Saur
MKMartin Christoph Konnerth
Martin Christoph Konnerth
SGStephanie Grond
Stephanie Grond
Lugdunin, a novel thiazolidine cyclopeptide, exhibits micromolar activity against methicillin‐resistant Staphylococcus aureus (MRSA). For structure–activity relationship (SAR) studies, synthetic analogues obtained from alanine and stereo scanning as well as peptides with modified thiazolidine rings were tested for antimicrobial activity. The thiazolidine ring and the alternating d‐ and l‐amino acid backbone are essential. Notably, the non‐natural enantiomer displays equal activity, thus indicating the absence of a chiral target. The antibacterial activity strongly correlates with dissipation of the membrane potential in S. aureus. Lugdunin equalizes pH gradients in artificial membrane vesicles, thereby maintaining membrane integrity, which demonstrates that proton translocation is the mode of action (MoA). The incorporation of extra tryptophan or propargyl moieties further expands the diversity of this class of thiazolidine cyclopeptides.

5 May 2020 in ACS Infectious Diseases
Verified
Journal Article
Closed access
JBJayesh Arun Bafna
Jayesh Arun Bafna
ESEulalia Sans
Eulalia Sans
SASilvia Acosta-Gutierrez
Silvia Acosta-Gutierrez
IBIgor Bodrenko
Igor Bodrenko
DHDaniel HörÖmPölI
Daniel HörÖmPölI
MCMatteo Ceccarelli
Matteo Ceccarelli

18 December 2023 in Nature Microbiology
Verified
Journal Article
Open access
PDF file
BSBenjamin O. Torres Salazar
Benjamin O. Torres Salazar
TDTaulant Dema
Taulant Dema
NSNadine A. Schilling
Nadine A. Schilling
DJDaniela Janek
Daniela Janek
JBJan Bornikoel
Jan Bornikoel
APAndreas Peschel
Andreas Peschel
Antagonistic bacterial interactions often rely on antimicrobial bacteriocins, which attack only a narrow range of target bacteria. However, antimicrobials with broader activity may be advantageous. Here we identify an antimicrobial called epifadin, which is produced by nasal Staphylococcus epidermidis IVK83. It has an unprecedented architecture consisting of a non-ribosomally synthesized peptide, a polyketide component and a terminal modified amino acid moiety. Epifadin combines a wide antimicrobial target spectrum with a short life span of only a few hours. It is highly unstable under in vivo-like conditions, potentially as a means to limit collateral damage of bacterial mutualists. However, Staphylococcus aureus is eliminated by epifadin-producing S. epidermidis during co-cultivation in vitro and in vivo, indicating that epifadin-producing commensals could help prevent nasal S. aureus carriage. These insights into a microbiome-derived, previously unknown antimicrobial compound class suggest that limiting the half-life of an antimicrobial may help to balance its beneficial and detrimental activities.

8 April 2022 in ACS Bio & Med Chem Au
Verified
Journal Article
Open access
SMSofia S. Mendes
Sofia S. Mendes
JMJoana Marques
Joana Marques
EMEdit Mesterházy
Edit Mesterházy
JSJan Straetener
Jan Straetener
MAMelina Arts
Melina Arts
Ligia SaraivaLigia Saraiva
Ligia Saraiva
Several metal-based carbon monoxide-releasing molecules (CORMs) are active CO donors with established antibacterial activity. Among them, CORM conjugates with azole antibiotics of type [Mn(CO)3(2,2′-bipyridyl)(azole)]+ display important synergies against several microbes. We carried out a structure–activity relationship study based upon the lead structure of [Mn(CO)3(Bpy)(Ctz)]+ by producing clotrimazole (Ctz) conjugates with varying metal and ligands. We concluded that the nature of the bidentate ligand strongly influences the bactericidal activity, with the substitution of bipyridyl by small bicyclic ligands leading to highly active clotrimazole conjugates. On the contrary, the metal did not influence the activity. We found that conjugate [Re(CO)3(Bpy)(Ctz)]+ is more than the sum of its parts: while precursor [Re(CO)3(Bpy)Br] has no antibacterial activity and clotrimazole shows only moderate minimal inhibitory concentrations, the potency of [Re(CO)3(Bpy)(Ctz)]+ is one order of magnitude higher than that of clotrimazole, and the spectrum of bacterial target species includes Gram-positive and Gram-negative bacteria. The addition of [Re(CO)3(Bpy)(Ctz)]+ to Staphylococcus aureus causes a general impact on the membrane topology, has inhibitory effects on peptidoglycan biosynthesis, and affects energy functions. The mechanism of action of this kind of CORM conjugates involves a sequence of events initiated by membrane insertion, followed by membrane disorganization, inhibition of peptidoglycan synthesis, CO release, and break down of the membrane potential. These results suggest that conjugation of CORMs to known antibiotics may produce useful structures with synergistic effects that increase the conjugate’s activity relative to that of the antibiotic alone.